Extractables and Leachables (E&L) Testing

Introduction Establishing a validated GMP Extractables and Leachables Testing program is an essential aspect of modern pharmaceutical development. It ensures […]

Introduction: Nitrosamine leachables in blister packaging have become one of the most closely scrutinized contamination pathways in oral solid dosage

Introduction Extractables & Leachables (E&L) Testing for Biosimilar Drug Development is a highly specialized, risk-based analytical approach developed to detect,

Introduction Obtain regulatory approval for IND, NDA, and BLA submissions with the support of professional Extractables & Leachables (E&L) Consulting

Introduction Extractables & Leachables (E&L) Testing for Veterinary Drug Products is an essential safety and regulatory requirement designed to ensure

Introduction Extractables & Leachables (E&L) Testing for Auto-Injectors involves the specialized chemical characterization and surveillance of substances that migrate from

Advanced Extractables & Leachables Testing for Ophthalmic Drug Products Evaluating extractables and leachables in ophthalmic formulations demands a detailed understanding

Introduction: Method validation for extractables and leachables testing is a regulatory non-negotiable — without a fully documented, ICH Q2(R2)-compliant validation

Introduction How Does a Comprehensive E&L Program Mitigate Risk in Prefilled Syringe Development? A comprehensive Extractables & Leachables (E&L) program

Regulatory Mechanisms Driving the Overlap of Elemental Leachables and ICH Q3D The principal intersection between elemental leachables and the toxicological